Role of Omega-3 Polyunsaturated Fatty Acid Supplementation in Patients with Type 2 Diabetes Mellitus
Last updated: 24 Dec 2024
10.21608/jampr.2023.235466.1058
omega-3, Type 2 diabetes mellitus, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), metabolic diseases
Rehab
Werida
H.
Clinical Pharmacy & Pharmacy Practice, Faculty of Pharmacy, Damanhour University, Damanhour 22514, Egypt.
rehabwrieda@pharm.dmu.edu.eg
Damanhour
0000-0002-5983-3993
Alaa
Ramzy
Ministry of Health and Population, Damanhour City, Egypt.
aalaaramzy2018@gmail.com
Yousry
Ebrahim
Nassief
Internal Medicine and Diabetes Department, Damanhour Medical National Institute, Damanhour City, Egypt
dr.yousrynassief57@gmail.com
Maged
Helmy
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Damanhour University, Damanhour, Egypt. Department of Pharmacology and Toxicology, College of Pharmacy, Arab Academy for Science, Technology and Maritime Transport, Alexandria, Egypt.
maged.helmy@pharm.dmu.edu.eg
Damanhour
0000-0003-0375-6762
5
1
46784
2024-03-01
2023-09-10
2024-03-01
8
14
2636-4158
https://jampr.journals.ekb.eg/article_320185.html
https://jampr.journals.ekb.eg/service?article_code=320185
320,185
Mini review
2,812
Journal
Journal of Advanced Medical and Pharmaceutical Research
https://jampr.journals.ekb.eg/
Role of Omega-3 Polyunsaturated Fatty Acid Supplementation in Patients with Type 2 Diabetes Mellitus
Details
Type
Article
Created At
24 Dec 2024